Wockhardt launches Midazolam in US

Ahmedabad, Nov 14 (UNI) India's Pharmaceutical and biotechnology major Wockhardt has launched Midazolam injection in United States after receiving approval from the American authorities for marketing the preservative-free version injections.

Midazolam is the generic name for the brand Versed, which is used for treating acute insomnia and anxiety. According to International Medicine Studies, the total market for Midazolam injections in the US is of 56 million US Dollar.

Sterile products continue to be a priority area for Wockhardt in the US. ''This is our fourth injection with Abbreviated New Drug Application approval in the past two months and the twelfth sterile product overall, Wockhardt sources said.

In the prescription generic pharmaceutical market, Wockhardt has been consistently growing market shares for all its products.

Wockhardt currently markets over fifty-five products in the US. The injections are manufactured at the United States Food and Drug Administration certified formulation plant at Waluj in Maharashtra.

UNI PVN RN NP1415